000 | 01310 a2200289 4500 | ||
---|---|---|---|
005 | 20250514035151.0 | ||
264 | 0 | _c20020718 | |
008 | 200207s 0 0 eng d | ||
022 | _a1175-2203 | ||
024 | 7 |
_a10.2165/00129785-200202010-00003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHagan, Christy R | |
245 | 0 | 0 |
_aMobile genetic element activation and genotoxic cancer therapy: potential clinical implications. _h[electronic resource] |
260 |
_bAmerican journal of pharmacogenomics : genomics-related research in drug development and clinical practice _c2002 |
||
300 |
_a25-35 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aDNA Methylation |
650 | 0 | 4 | _aDNA Transposable Elements |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMutagens _xadverse effects |
650 | 0 | 4 | _aShort Interspersed Nucleotide Elements |
650 | 0 | 4 | _aTranscription, Genetic |
700 | 1 | _aRudin, Charles M | |
773 | 0 |
_tAmerican journal of pharmacogenomics : genomics-related research in drug development and clinical practice _gvol. 2 _gno. 1 _gp. 25-35 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/00129785-200202010-00003 _zAvailable from publisher's website |
999 |
_c11978541 _d11978541 |